Metabolic Diseases—New Markers and Treatment Pathways
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Endocrinology and Metabolism Research".
Deadline for manuscript submissions: 31 July 2026 | Viewed by 24
Special Issue Editor
Special Issue Information
Dear Colleagues,
Metabolic diseases encompass a broad range of disorders affecting the body’s metabolism, including diabetes, obesity, and inherited metabolic disorders. Recent advances in biomedical research have identified new biomarkers that may improve the diagnosis, monitoring, and treatment of these conditions. Biomarkers such as circulating metabolites, inflammatory markers, and genetic variations offer insights into disease mechanisms and progression.
Novel treatment pathways are emerging, leveraging these biomarkers for personalized medicine approaches. For instance, the role of gut microbiota in metabolic health has prompted investigations into microbiome-targeted therapies, including prebiotics and probiotics, which may alter metabolic profiles favorably. Additionally, advancements in gene editing technologies, such as CRISPR-Cas9, are being explored to correct specific genetic defects underlying certain metabolic disorders.
Pharmacological developments include new classes of anti-diabetic medications that target metabolic pathways, potentially improving glycemic control while reducing cardiovascular risks. Emerging therapies also focus on the hormonal regulation of appetite and energy expenditure, aiming to tackle obesity at its roots.
Understanding the interplay between genetic, environmental, and lifestyle factors is crucial for developing effective interventions. Continued research into these new markers and treatment strategies offers hope for improving outcomes and the quality of life for individuals affected by metabolic diseases.
Prof. Dr. Anna Różańska-Walędziak
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabolic diseases
- diabetes
- obesity
- biomarkers
- anti-diabetic medications
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
